Association Between HER2-Low Status and Survival Outcomes in Patients With Metastatic Breast Cancer Treated With CDK4/6 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis
Breast Cancer Res Treat 2024 Jan 19;[EPub Ahead of Print], DC Guven, TK SahinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.